STAYMORY DESIGN — 2165962
Application number
2165962
Registration number
TMA1358624
Type(s)
Design
Category
Trademark
CIPO Status
REGISTERED
TM5 status
LIVE/REGISTRATION/Issued
and Active
The trademark application has been registered with the Office.
Filed
2022-02-10
Registered
2025-11-14
Registration Expiry Date
2035-11-14
Registered Owner
Hisamitsu Pharmaceutical Co., Inc.
408, Tashirodaikan-machi
Tosu-shi
Saga 841-0017,
JAPAN
Agent
BORDEN LADNER GERVAIS LLP
World Exchange Plaza
100 Queen Street, Suite 1300
Ottawa
ONTARIO K1P1J9
Documents
Index headings
- STAYMORY
Goods (Nice class & Statement)
- 5
- (1) Medicated transdermal patches, plasters, pads, cataplasms and creams for the relief of aches of rheumatoid arthritis, and the aches and pains of muscles, joints and tendons; anti-inflammatories and analgesic preparations; other pharmaceuticals in the form of patches, plasters, pads, cataplasms and creams for use in the treatment of lumbago, namely muscular and fascial lumbago, spondylosis deformans discopathy, and sprain of lumbar spine, osteoarthritis, humeroscapular periartebritis, tendonitis, tendovaginitis, peritendinitis, humeral epicondylitis, tennis elbow, myalgia and post-traumatic swelling and pain; antiphlogistic and analgesic spray for the temporary relief of minor muscular aches and pains; antiphlogistic and analgesic gel for the temporary relief of minor muscular aches and pains; gauze for dressings; empty capsules for pharmaceuticals; eye patches for medical purposes; ear bandages; menstruation bandages; menstruation tampons; sanitary napkins; sanitary panties; absorbent cotton; cotton for medical purposes; cotton swabs for medical purposes; adhesive plasters, namely, adhesive bandages, surgical adhesives, medical plasters; bandages for dressings; breast-nursing pads; dental cements, dental prosthetics and fillings, dental wax, materials for artificial teeth; medicated patches for the treatment of alzheimer-type dementia; pharmaceutical preparations for the treatment of alzheimer-type dementia; pharmaceutical preparations for the treatment of central nervous system diseases and disorders.
Action History
| Action | Action date | Due date | Comments |
|---|---|---|---|
| Filed | 2022-02-10 | ||
| Created | 2022-02-10 | ||
| Formalized | 2022-02-10 | ||
| Pre-Assessment Letter Sent | 2022-07-14 | Retired Goods or Services | |
| Search Recorded | 2025-02-07 | ||
| Examiner's First Report | 2025-02-07 | 2025-08-07 | |
| Approved | 2025-06-12 | APPROVED BY PROGRAM EX200M1 | |
| Approval Notice Sent | 2025-06-12 | APPROVED BY PROGRAM EX200M1 | |
| Advertised | 2025-08-27 | Vol.72 Issue 3696 | |
| Registration Pending | 2025-11-14 | ||
| Registered | 2025-11-14 | 2035-11-14 |